|Dr. Jurgi Camblong M.B.A., Ph.D.||Co-Founder, CEO & Director||N/A||N/A||1979|
|Mr. Ross Jordan Muken B.Sc.||Sr. VP & CFO||N/A||N/A||1980|
|Mr. Abhimanyu Verma||Sr. VP & CTO||N/A||N/A||N/A|
|Dr. Zhenyu Xu Ph.D.||Sr. VP & Chief Scientific Officer||N/A||N/A||1982|
|Jennifer Pottage||Head of Investor Relations||N/A||N/A||N/A|
|Mr. Daan van Well L.L.M., M.B.A.||Sr. VP, Chief Legal Officer & Gen. Counsel||N/A||N/A||1974|
|Ms. Manuela Da Silva Valente B.A.||Sr. VP & Chief People Officer||N/A||N/A||1970|
|Dr. Thierry Colin||Sr. VP of Radiomics Bus. Area||N/A||N/A||N/A|
|Dr. Philippe Menu M.B.A., M.D., Ph.D.||Sr. VP & Chief Medical Officer||N/A||N/A||1981|
|Ms. Lara Hashimoto||Sr. VP & Chief Bus. Officer||N/A||N/A||N/A|
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
SOPHiA GENETICS SA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.